#FCI #Masterka #World #Premiere #LacriJet #AAO #Industry #Showcase #Presentation
[ad_1]


Industry Showcase Presented by FCI during AAO Virtual Meeting.

William R. Katowitz, MD presents Masterka® study results and Reynaldo M. Javate, MD, FICS presents Masterka® experience and the upcoming world premiere LacriJet® “pushed” monocanalicular stent.

LacriJet® is FCI latest and exclusive preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration.

Learn more at:
https://fciworldwide.com/products/lacrijet
Coming soon! Pending FDA approval

Masterka® is FCI innovative solution for the treatment of congenital nasolacrimal duct obstruction resistant to probing. Unlike the traditional “pulled” technique, Masterka® has no metallic probe or suture attached to it and is therefore not pulled out of the nose.

Learn more at:
https://fciworldwide.com/products/masterka
https://fci-ophthalmics.com/products/masterka

Follow us on LinkedIn:
https://www.linkedin.com/company/fci-ophthalmics/
[ad_2]

dratef